Ad blocker detected: Our website is made possible by displaying online advertisements to our visitors. Disable your ad blocker to continue using our website.
Ranbaxy Laboratories Ltd announced on Tuesday an exclusive in-licensing agreement with CD Pharma to market the Inersan brand in India and Nepal.
The patented product, a probiotic preparation, is used for the treatment of dental problems such as periodontitis, gingivitis and halitosis. Presently, there is no particular drug available for the treatment of this dental problem. Inersan, a natural biological product, would be the first-of-its-kind to be introduced in India.
I can't find any information besides pubmed saying these are "lactobacilli lozenges" which makes it no different than yogurt. The company creates a very high-potency probiotic product containing 250 billion bacteria called VSL#3, so Inersan could be a concoction with very high concentrations of bacteria in the form of a lozenge. It could very well be the same product, in lozenge form, made for India/Nepal
Hello, I'm Jimi Stein, the owner of the world's largest bad breath site. Currently, we're in need of funding to keep the site operational. We're unsponsored and heavily rely on your generosity. If you can, please donate to help us maintain this truth-focused platform. We've integrated Google AdSense, but it only generates 50 cents a day, and the site already has too many ads. Your contribution is crucial to keep us running. We've never compromised our commitment to truth, and with your support, we can continue to provide valuable 100% truthful content. Thank you for considering a donation to keep our site alive.